BioAge Labs BIOA
NASDAQ BIOA
$5.52 -0.04 (-0.72%)
As of: Oct 21, 2026 · 3:59 PM EDT

BioAge Labs (BIOA) Revenue (2025 - 2026)

Updated

BioAge Labs (BIOA) posted Revenue of $2.45 million for Q2 2026, up 1.6% from $2.41 million a year earlier but down 11.6% from the prior quarter.

Analysis

BioAge Labs (BIOA) Revenue (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at BioAge Labs was $10.36 million, up 168.1% year-over-year; for FY2025, it came in at $9 million.

  • Quarterly Revenue has run from a low of $1.45 million in Q1 2025 to a high of $3.08 million in Q4 2025 over five years.
  • According to Business Quant data, Revenue for the three prior quarters was $2.77 million (Q1 2026), $3.08 million (Q4 2025) and $2.05 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 16.99 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 7.80 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 15.03 Bn
10 BioAge Labs 245.72 Mn -1.55 Bn -14.23 Mn 2.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.45 Mn
Mar 31, 2026 2.77 Mn
Dec 31, 2025 3.08 Mn
Sep 30, 2025 2.05 Mn
Jun 30, 2025 2.41 Mn
Mar 31, 2025 1.45 Mn
API Access

BioAge Labs Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=BIOA&period=max&api_key=YOUR_API_KEY